"We look forward to closing the transaction and realizing the significant benefits created by joining our more than 5,000 employees, geographic footprints, highly complementary innovations, customer bases and leading portfolios," NuVasive CEO Chris Barry said in a news release.
"Globus Medical shareholders showed an overwhelming level of support for this merger," Globus Medical President and CEO Dan Scavilla said in a news release."Our combined company will have one of the most comprehensive offerings of musculoskeletal solutions and enabling technologies to help surgeons treat their patients."
The merger is slated to close after clearance from regulatory authorities.
Note: This article was updated April 28 to include information from Globus Medical.